by 
Orodispersible tablets are solid dosage forms that disintegrate or dissolve rapidly in the oral cavity without need of water. They provide convenience of administration for people with difficulty in swallowing including pediatric and geriatric patients. The global orodispersible tablets market demand is growing owing to the increasing patient pool suffering from dysphagia and the focus on patient-centricity. The global Orodispersible Tablets Market is estimated to be valued at US$ 4.9 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing geriatric population is one of the key factors fueling the demand for orodispersible tablets globally. It is estimated that by 2050, approximately 16% of the world’s population will be aged 65 and above. As aging increases the risks of dysphasia and difficulty in swallowing, orodispersible tablets provide an easy mode of drug administration for the elderly population. Their easy portability and immediate solubility without water further enhances patient convenience and compliance for medications among geriatrics suffering from multiple co-morbidities. With rising life expectancy, the demand for geriatric-friendly drug formulations like orodispersible tablets is likely to increase significantly over the coming years.
SWOT Analysis
Strength: Orodispersible tablets dissolve quickly in the mouth without water, which provides ease of administration for patients who have difficulty in swallowing tablets and capsules.
Weakness: Orodispersible tablets have less shelf life as compared to conventional tablet dosage forms due to their porous structure which makes them vulnerable to moisture.
Opportunity: Increasing prevalence of dysphagia especially among pediatric and geriatric patients is creating growth opportunities for orodispersible tablets market.
Threats: Presence of alternative dosage forms like liquids and chewable tablets hinders the growth of orodispersible tablets market to some extent. Stringent regulatory policies for approval of new drug delivery technologies also poses a threat.
Key Takeaways
The global Orodispersible Tablets market is expected to witness high growth. The market size for 2024 is 4.9 Bn with a CAGR of 8.1% during the forecast period of 2023 to 2030.
Regional analysis: North America dominates the global market due to rapid adoption of novel drug delivery systems and presence of major players in the region. Asia Pacific is expected to grow at fastest pace owing to rising healthcare expenditure and increasing economic activities in emerging countries of China and India.
Key players: Key players operating in the Orodispersible Tablets market are Alnylam Pharmaceuticals, IntelGenx, Pfizer, Bristol-Myers Squibb, Biovail, Cipla, and GlaxoSmithKline.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
